ML20056H608
| ML20056H608 | |
| Person / Time | |
|---|---|
| Issue date: | 07/30/1993 |
| From: | Remick NRC COMMISSION (OCM) |
| To: | Chilk S NRC OFFICE OF THE SECRETARY (SECY) |
| References | |
| NUDOCS 9309100186 | |
| Download: ML20056H608 (1) | |
Text
'"
.,c.,......
.,s
~,
g NOTATION V 0 T E:
.,cl4]l9E _CL :: i RESPONSE SHEET t .. z A......, ...~ T0: SAMUEL J. CHILK, SECRETARY OF THE COMISSION l FROM: C0l44ISSIONER REMICK l
SUBJECT:
SECY-93-205 - PROPOSED MEMORANDUM 0F l UNDERSTANDING BETWEEN THE FOOD AND DRUG ADMINISTRATION AND THE NUCLEAR REGULATORY C0144ISSION g,-,.~ f APPROVED X DISAPPROVED ABSTAIN NOT PARTICIPATING REQUEST DISCUSSION l C0144ENTS: pk < .ru a gcb / 1 l l l i i UV' SIGNATURE RELEASE VOTE /X / 7' N'N 9 3 DATE WITHHOLD VOTE _/ / ENTERED ON "AS" YES < N0 f lSA"88ARI TS8? CORRE3PONDENCE PDR I - - -.i
I r e I i Comments of Commissioner Remick on SECY-93-205 I approve the proposed Memorandum of Understanding (MOU) between i the U.S. Food and Drug Administration (FDA) and NRC, provided that the staff makes two modifications to the proposed MOU. i I First, the staff should ensure that the definition of nuclear material covered by the MOU is used consistently and f appropriately throughout the MOU. In some places, the MOU refers i only to by-product material, while at other times it refers to j by product, source, and special nuclear material, or nuclear and i other radioactive materials. Second, the staff should ensure that the MOU adequately considers the recent proposal of using boron neutron capture therapy for the treatment of brain cancer. l l With the appropriate modifications made to accommodate these two i l concerns, I approve the subject NRC/FDA MOU. I l ( i l t ,}}